Navigation Links
Enbrelr Enters Safer Zone After Recent Research

Latest studies have declared ENBRELR (etanercept) safe to be used to treat psoriasis up to an extended period of two and half years//. The result of the current studies were presented at the 15th European Academy of Dermatology and Venereology (EADV)Congress . ENBREL is a 'Biologic Medicine which means it is synthesized using recombinant DNA or rDNA derived protein using current principles of biotechnology.

This biologic medicine acts by inhibiting one of the main mediators which triggers off inflammatory processes. Enbrel happens to be topmost biologic therapeutic clinically approved worldwide, It is also less cumbersome for patients as it is marketed in convenient 25mg and 50mg syringes making it most adaptable for treatment purposes.

Bruce Strober MD PhD, co director of the Psoriasis and Psoriatic Arthritis Center at New York University mentions that that these findings are very significant as it confirms the parameters within which Enbrel is safe to be used, and also provides valuable information regarding the use of other biologic medicines as well in the long run.

About 5.1 million people is affected by Psoriasis in U.K alone, according to statistics. The most common type of Psoriasis presents itself in the form of plaques over affected skin surface characterized by thickening of skin which looks reddish with superfluous flaky white scales which fall away on being scratched. Most common symptoms associated with these lesions are severe intolerable itching and redness of skin apart from the drying and scaling away of skin. It is probable that an abnormal response from the immune system of the body cause the skin cells to grow and multiply excessively.

In the 48 week Open Label study that was conducted it was clear that ENBREL produced no unpalatable side effects with extended dosages upto2.5 years when compared with randomized Placebo controlled Parent Studies. No further safety signals were iden
'"/>




Page: 1 2

Related medicine news :

1. More Doctors Suspended As Strike Enters Seventh Day
2. Doctors Strike In Andhra Enters The Second Day
3. Anti-Quota Stir: Stalemate Continues; Fast Enters 10th Day
4. AIIMS Strike Enters Second day, Support Continues To Pour In
5. JIPMER Strike Enters Eighth Day
6. The Food Pyramid Guide Enters Supermarkets
7. Vandetanib Study Enters Third Phase
8. Crucells Rabies MAb Enters Phase I Trial in India
9. Heart Surgery Is Getting Safer for the Old
10. Estrogen Patch is Safer than Pills for Heart
11. Traffic Violations Result in Safer Drivers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Enbrelr Enters Safer Zone After Recent Research

(Date:6/1/2015)... 01, 2015 EBSCO Health , ... introduced DynaMed Plus™ , a cross-platform evidence-based clinical ... It provides clinicians with the ideal blend of evidence ... paths. , DynaMed Plus is a significant enhancement ... the most frequently updated evidence-based content. DynaMed Plus content ...
(Date:6/1/2015)... June 01, 2015 KC and Monica ... $88,000 of the best superfood products in ... floods in Texas. , "Monica and I are ... News in distributing Living Fuel Super Meals - SuperBerry®, ... millennial floods in Texas," KC Craichy said. "We have ...
(Date:6/1/2015)... Atlanta, GA (PRWEB) June 01, 2015 ... leading publisher of clinical journals in the areas of ... pleased to announce that it has expanded upon its ... newest journal, Hospital Medicine Practice, in a mobile ... smartphones and tablets. , “We are very excited ...
(Date:6/1/2015)... The session, entitled “Building the Blueprint ... president of Elektrobit Automotive Americas, senior representatives from ... will be moderated by Andy Gryc of CX3 Marketing. ... complexity of in-vehicle software in connected vehicles and autonomous ... how the wider ecosystem can fit into new vehicle ...
(Date:6/1/2015)... 2015 Strategic Radiology (SR) announced today ... joined forces with the SR coalition of progressive, independent ... alignment, RRG will now have access to collective resources ... clinical quality, and deployment of subspecialized radiology services. With ... member and affiliate US based radiology group practices. ...
Breaking Medicine News(10 mins):Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 4
... (NYSE: WST ) today announced that Donald E. ... Federici, Chief,Financial Officer, will be presenting at the 2008 ... 11, 2008 in New York City., A copy ... the,investor link of the Company,s website at http://www.westpharma.com ...
... BIOSAFE Laboratories, Inc.,the developer of the BIOSAFE ... have announced the availability of a limited,number of ... identify diabetic and,pre-diabetic children and adolescents. The BIOSAFE ... an immediate fasting glucose reading and,a mail-in laboratory ...
... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ... that it closed its previously announced initial,public offering ... that the,underwriters of the offering have exercised their ... stock from the selling,stockholders at the public offering ...
... (OTC,Bulletin Board: SNKTY), a Life Sciences company engaged ... of healthy aging, today announced,the debut of Pyratine-6(TM) ... of Dermatology in San Antonio, Texas., Pyratine-6(TM), ... to be effective in correcting visible signs of ...
... EnterpriseIQ Supports Device Manufacturer,s Continued Growth and Compliance, ... a leader in the,design and development of Enterprise ... II Medical Manufacturing for its comprehensive ERP,software, EnterpriseIQ. ... medical,device manufacturing industry, so does the level of ...
... Center had sleeplessness, other problems, study shows , , TUESDAY, ... the World Trade Center terrorist attacks boosted behavioral problems ... researchers at the Mount Sinai School of Medicine in ... years of age who lived in or attended preschool ...
Cached Medicine News:Health News:West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 2Health News:BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessment Kits to U.S. School Children 2Health News:IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option 2Health News:Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology 2Health News:Phase II Medical Manufacturing Selects IQMS for ERP Solution 2Health News:Phase II Medical Manufacturing Selects IQMS for ERP Solution 3Health News:9/11 Exposure Linked to Behavior Trouble in Kids 2
(Date:6/1/2015)... Research and Markets  ( http://www.researchandmarkets.com/research/4lw2mn/global_a_dialyzer ) ... A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor ) ... The Global A Dialyzer Reprocessing Machine ... a professional and in-depth study on the current ... The report provides a basic overview of ...
(Date:6/1/2015)... 1, 2015  Boston Biomedical, an industry leader in ... stem cell (CSC) pathways, will present clinical data today ... tumor types at the 2015 American Society of Clinical ... . Data presented at ASCO highlight the ... targets STAT3, leading to inhibition of the critical genes ...
(Date:6/1/2015)... YORK , June 1, 2015   ... of Open, Transparent and Connected financial marketplaces for ... Incorporated, a San Diego -based ... traded on OTCQB®, America,s only public venture market ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 2Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 4Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 5Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 6Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 7OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... InVitria,( http://www.InVitria.com ), a leading global ... safety and time to market for companies,in ... and,diagnostics industry, will be an exhibitor and ... in Anaheim, California on September,23-26. ( http://www.ibclifesciences.com/B8171/overview.xml ...
... Bionovo, Inc.,(Nasdaq: BNVI ) today announced ... for,the American Society for Pharmacology and Experimental Therapeutics, ... of,Liquiritigenin, a Bioactive Compound Isolated from the Chinese ... one of the active compounds of MF101, Bionovo,s ...
Cached Medicine Technology:InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 2Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate 3
... with 3 charging wells. Available In 4 ... and Cinnamon. Spring balanced refractor and slit ... construction for lifelong quality. Sealed hydraulic system ... movement. Chair back reclines manually to fully ...
... the patented HydroKeratome corneal cutting device for ... industry experts believe it will replace the ... used in the LASIK refractive procedure. In ... has demonstrated that its proprietary technology is ...
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Coaxial Ophthalmoscope Set with Convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Medicine Products: